輸血ハンドブック - 近畿大学医学部
Contents
1.2. 181 8 2012 8 1
3. 55 1998 4
4. 35 145 68 7 3 1
5. 5 1 3
6. 1 2 3
7. 11 00 92 Rh Rh D 32 HLA HLA ABC HLA
8. 3 53 x x 54 48
9. 2
10. a 110 1
11. 34 2011 12 1 10 26 ID NO 91919191 O Rh 46 2011 8 2 2003 11 17 B 2006 11 1
12. 18 7 59 4 127 25 1 2 4 1 1
13. RCC FFP PC 3 1
14. 1 2 3 4
15. 3 l 2 3 MAP 4 RC MAP In 20C 4C 18
16. 0 5 1 0m 1 ID 24 9191
17. 1 WRC R 1 30 94 Il 1 2 IgA IgA
18. HE 4 2 HB22 12 1 49 2 22 1 1 9 1 1
19. 2 62
20. 2 180 4 1 2 O RCC LR 0
21. GVHD 19 1 1 1 Hb 8g dL
22. 1 2 3 4 5 6 7 8
23. 2 1 2 12 2 10 2 9
24. 1 50 1 2 1 1 3 1 B 15 1 3 2000 RR 2003 gt
25. 16 50 1 X 72 _ PEEP 706
26. Fe 100 6 GVHD ES GVHD GVHD HLA HLA 1 1
27. 10kg 3 4L 1 4
28. 5 6 3 51
29. 83 42 Ver2 23 12
30. hl
31. 27 91919191 zzsy 91919191 43 Bs ABO BE Rh 2007 08 26 2006 11 01 2007706 22 2 190 2191
32. HES TTP HUS 4
33. 2 i 179 I I 20 12 1 1
34. 2 ll ABO Rh a 0 O 4 L D 5 HLA ABC DR DNA PRA ABO
35. F 2 1 2 3 SpO2 4 PDA 1 5 10 1ml 5ml 5 5 SpO2 PDA
36. Il D 1 024 4 096 lt 8 192 UTD 26 28 PA FFP PPF 1500ml 2500ml 28 32
37. p 1 ABO ABO RhD D ABO RhD ABO O
38. 3 1 2 1
39. GVHD HBV HCV HIV HTLV I HIV 1
40. 177 2 Q 2 3 In Il 2 fH L
41. 53 2008 2 28 1 18 1 15 5 18 1 18 4 15 797 961 1 18
42. 139 8 2 200mmHg 95mmHg 120 1 1 387C 37 2C CRP WBC
43. 154 X PBSCH En PBSCH Peripheral blood stem cell PBSC CD34 Peripheral blood stem cell transplantation PBSCT PBSCT PBSCT PBSCT PBSC PBSCT BMT
44. 1 200mL 1 8 169 2 6C LR 400mL 2 16 338 21 200mL 1 LR 400mL 2 9 207 2 6C Y 18 414 24 ul 200mL 1 400mL 2 15 202 2 6C 30 404 12 200mL 1 400mL 2 13 124 2 6C ABO 26 247 24 uu
45. 3 1 1 4
46. 100mg dL 450mL 1g 60kg 83L 30mg dL 3 5 mm3 60kg 10 2X101H 25 000 mm3 4 3L 40
47. 7 3 103 16 4 1
48. 2 3 4 5 2 1
49. 4 1 7 3 1
50. 2001 15
51. 2 A I In 0 SN HH HH IL In 2005 9
52. 1 2 ABO 3 4
53. BE A A 1 59 0 30 1 A
54. FE 1
55. EPO 1 800ml 1 70kg 13g dl 70kg 14g dl 2 E
56. DIC GOT GPT LDH 1 BUN 1 DIC FDP 1 1 4 10 0 RCC LR AB FFP HH HHT 86 ABO
57. 4 2006 10 21 59 9 60
58. 4 6 25 4 5
59. 104 2 3 HB s H CV GOT GPT H IV 4 H I V 1 2 H I V 4 105
60. HB OO3109 goB n1 A 45 169 3cm 43 2kg 8 RI Di82011 0 PB991111234 FFP 1 8B EC _ ig iss sa ss 2 1 5 15 F Rs WE See ol E
61. O RhOD ABO Rh D Rh ol nN Il 1 200ml 1 Ver 2
62. FFP TICU FFP 30 3 7 4 3 RCC LR 6 3 0 3 4
63. MVD A CEA 8 LA J TUR P 4 TVP MSBOS _ 4 4 4 6 4
64. lt DB gt 3 gt ABO 0 0 ABO Rh A B 0 Rh AB A B 0 RhOD
65. 5 10 15 0 eh 3 ry TO 0
66. gt 2 44 1 2 3 4
67. 2007 5 25 2
68. 5 65 50 100 1 000mL 1 24 100 100mL nn Hb 7 8g dL Hb 10g dL
69. 0 V 3 H 1 2 2 6 20 24 3 h 20C Ii
70. 30 5 10 m1 hr 1 Il H In PBSC H 8 9 1
71. ACD Ca 3 4 1 PBSCT PBSC 2
72. 1 Dz B P0031569 308 01 Ni 4 169 3cm 3 2kd 8 FE 0 aaaaewosmry 2
73. PT APTT 1 1 1 PT APTT GDPT G INR 2 0 Gi 30 APTT i 2 Gi 25 PT INR 2 0 30 DIC 1 PT APTT 10
74. RCC LR 17 PHS6081 11 00 12 00 13 00 8 11 10 EDTA 4ml
75. 163 6 PBSC 1 PBSC G CSF 1000 500 1 2 4 CY VP 16 A r a C BNCU melphalan thiopepa CDDP 2 G CSF gt G CSF 50 000 nL G CSF
76. 2 3 VVR 3 150 Dl vs LT 131 4
77. hn Y 1 Il L gt 1n ll 5 10 20 30
78. 1 MAP FFP 11 00 _ 2003 11717 200d 11 17 _ 2003 11 17 2007 06 22 mi Dr _ 2008 10 30 _ as nn _ G ID
79. 3 4 Js 5 5 1 PBSCT PBSCT
80. 6 EPO 1 4 7 1 4 2
81. 1989 1994 1999 4 1992 D gt 5 5 1985 62 8 2007 40 1995 95 9 2007 11 19 3 5 2 3 15 0
82. O 37
83. 5 1 g 1 124 1 1993 8 2010 12 E 10 Tc C e 2 95 3 C 1 6 2 2 1 M Ja 72 4376 4471 2 1991 8 2010 12 HLA 741 HPA5b HLA Naka HLA HPA5b HPA4b HPA5a HPA4b HPA5b Naka HLA 746 13 2 MP Pw AIF FP KK HPA 41 0 7 4864 5646 125 VI El AB0 AN ml 1 2 3
84. 147 3 1 6000IU 3 1 24000IU 1 13g dl 1 1 800ml 2 1200ml 3 1 2 3 4 14gd1l 42 4 GOTGPT tl NS El 4 5
85. 2 GMAP 42 Yersinia Enterocohtica L M A P 7 4 1 21 MAP 134 2 4 5 151 154
86. BUN Creatinine c 7mEq L BUN 120mg dl Creatinine 6 0mg d1 HCO 15mmo1 L BUN 20mg d1 88 2 DIC
87. C 1 1 1 7 4 5
88. Cc 1 1 1 1 PDA NN
89. NAT 15 HI V 1997 4 Ver 2
90. EE 1 6 VVR 1 VVR 0 13 2 33 1 YVR 1 5 VVR 1 VVR
91. 17 9 24 3 1986
92. 3 17 7 6
93. 170 RE Il 172 2 Il 174 1 i dd RSS 175 2 176 1 Il FE ee 176 2 CT CO 9 0 176 3 ee 176 4 a Ce 176 3 176 1 176 2 177 3 SA a ed 177 4 177 5 RS SE NS SE 177 4 ee 177 1 pp ER NA RE A 177 2 Il 178 3
94. 20 30 40mL kg 70mL kg 1 Ht 100 100 20 309 8 12mL kg 40mL kg 20 30 1 2 3 4 5 DIC 1 2 3 4 71 5 1
95. 25 91919191 91919191 43 Li P MD mm O 1 2 3 3 0
96. 153 12 4 Hb 5
97. HLA RCC LR 90 I
98. hl nmn 20G 40 60m1 22 24G 20 50m1 1 nm 1 20 kg 1 TBV 1 1 3 L 10 15 1 1 Spectra TBV 15 ITBV 10 AutoPBSC 165 ml 1100 ml 1650 ml TPE 165 ml 1133 ml 1
99. INFECT ION 5 1 1 CPDA MAP MA P 2 1 7 7 7 7 y 0
100. DPO FPO FPO lw a FPO 148 I 1 I 9 3 IV 4 V 5 1 ASA American Society of Anesthesiolosists physical status 80
101. 2 Ht 600ml 600ml 2 Ht 22 600ml Ht 20 400ml 600ml 30
102. 0 DIC 5000 IV 1500 6 24 DIV FOY1000 2000mg DIV 3 FOY
103. 2 MP 300 A ee 2 ME BP 102 XX BP165L 4 1 2 3 4 17
104. 1 1 2 2 18 1 15 18
105. HIV 2 8 3 90 B19 EB 1
106. G CSF PBSC G CSF 4 1 PBSC 2
107. 1 15 SEQ NO _ 2011 12 1 LR 4 0 No on rR DD 2011 12 01 gt lere1o 1 Ne SEQ _1201 00021 2011 12 01 10 35 13 SEQ 2011 12 01 00021 D 91919191 A OO RCC LR 2 72 0725 1155 11 12 13 72 0725 1140 11 12 12 36 HH 5 DABO 1 1L
108. 2191 ul 1 2 2 3
109. IN 60 12 2 3 2 60 10 B 15 4 63 8 20 3 4 63 C 5 12 2 29 4
110. 204 i
111. INFECT ION 4 1 0 1
112. 589 8511 377 2 TEL 072 366 0221 2191 182
113. 6 2 000ml 1 OD 1 7 QO ni Hb 1
114. 2 3 4 5
115. Wb R RE E te
116. 113 lt 114 118 119 HDN 120 D ee 121 LL 122 122 NAITP 122 NAIT 123 TTP 124 125 VWI ABO
117. 96 4 _ 5 5m 1 O D transfusion associated circulatory overload TACO _ I HH 1
118. HLA 31 FEP 1 2 Lh 1 12 30 14 00 2 15 00 16 00 1
119. 0 5 L 1 5 UTP TTP ITP
120. PBSCH PBSCH CD34 PBSCH IS 155 PBSCT 1 PBSC G
121. 2 10 12 14 16 10 12 3 1 144 1 1 1
122. 27 28 HLA 30 Rh D Rh 32 Rh Rh 33 34 1L 35 1 36 tt u 37 i i 39 SS EG RE Ns 40 HIT 41 IV 42 43 i ED RI RG EE 46 47 54 1
123. 2 W 1L 400ml 1 W 1 400ml day 0 2 1 10 400m 1 g ml 1 05 g 400ml g 400X1 05 g 40 45kg 300m 1 40kg
124. a 5 15 17 19G 22G 24G 24G 10 1 1ml 5mT 1 RCC LR WRC LR 400ml RCC LR 3 6 50mT 200m 2 30 37 3 4 6C 3 PC 10 10 200m1l 30 1 RCC LR
125. ID 145 1 2 3 4 5 1 2 4C
126. 1 2 3 4 TRALI transufusion related acute lung injury HTLV HIV GVHD graft versus host disease 16 IV 1 2 1 2 3 4 ON 5
127. 5 1 2 0 3 3506 9 4 1 1 111
128. W gt Hb 7g d 1 Il Hb 1 Se MAP 20 kg 1 TBV 1 1 1 Il
129. 70 2 100mg dL DIC 2 C S 3 PT APTT TTP TTP TTP HUS
130. 24 2 NYHA New York Heart Association Classification of CardiacPatients I I IV 149 3 VVR 1 gt 407 l lt 90mmHg
131. 5 130 1 ke
132. 6 Hx 10 4 24 24 7 20 173 3 23 11 28 174 1 61
133. 5 HLA 4 6 HLA 7 ln 2 5 7 HLA PC HLA ABO HLA 0 A AB O
134. 1 1 2 2 3 8 ho 1 ABO 4Aa yy 1 2 2 ABO 3 3 ABO 9 1 ABO 2 ABO A gt AB gt B A gt AB gt B B gt AB gt A B gt AB gt A AB gt A B 18 lt 1 2
135. 1 1 17 9 17 9 6 0906002
136. 158 G CSF lt 100 000 L 50 G CSF G CSF G CSF 7 1
137. 2ml 3 2ml 2 0 TID BOX BOX 850 BOX 14 565 8565 5 7 06 6833 5012 2294 smiyata hsp ncvc go p 41 IV
138. 2 D 2ml AV000 D DD 28w D D 3 D
139. 1 159 I 4 000ml 600ml 1 nn T amp S ln 6 a 40kg 6 Il 7 In
140. ln CPD CPDA 1n 143 II 3 HBV HCV HIV HTLV I
141. 1 1 lt 4 8 2 1 1 1 1 li n 140 LA nm
142. 2 5 zL n gt Neonatal Alloimmune Thrombocytopenia NATT human platelet antigen HPA IgG 2 1 20mL 0 2X101 3kg 240mL 20mL PC 5 5 7 L
143. 30 15 MSBOS Maximam Surgical Blood Order Schedule 1 5 15 T amp S MSBOS 1 T amp S 2 11 T amp S
144. In 2 lt 2 1 1 1 In L Ih 1 2 L Heparin Induced Thrombocytopenia HIT 1 L 1 1 2 Il x 2 3 mL X103 Il 70 mL kg 5 0X10 5 000mL 71kg
145. 2 HDb 6gdL 2 Hb 10g dL 6g dL Hb 3 1 10 30 Hb 10g dL Ht 30 2 20 50 HES
146. 1 a Im 1 Il 132 1 D I C 1
147. 4ml 3 L 20 80 60 4 Ii 0 5 1 0ml 5 PC 2190 2191 PHS6081 PC
148. 2003 3 SE NR E 31 160 15 7 We 1 es EE j 1 NR ee
149. 5 14 9 5 14 DIC 91 DO PTP HPA la P1
150. Hb7 8g dl Hb 8 SBOE 1 ml 2 Hb g dl Hb Hb Hb Hb 10gdl Hb 11 12 g d 1L
151. 50 100 In 1 5 55 38 7
152. 49 52 53 47 2 1 15 2 3 4 48 Mi 1 1
153. 17G 21G 3 NYHA ABO Rho Hb Ht DHb Ht Hb 11 0g dl H t 33 0 RA H b 11 0g dl Hb
154. 1 HLA 2 3 1 E 1 2 3
155. 2 3 4 3 1L LOTNO L 36 n FFP FFP 1 1 25 1 2 2 yy 3
156. 1 D 5 6 D Q1 2 1 30ml 0 3 30m1 121 Mee nl Alloimmune Thrombocytopenia NATT 14 HLA 13 HPA 0 7 NAIT 1 8000 2 1 NST
157. 2007 04 2007 11 1I 1 8 1 In
158. 81 VI 1 83 2 ee 84 3 1 ABO 86 ABO rr 87 ABO 87 ABO 1 RR 90 ABO Il 91 92 2 1 L LL 1 eo NA O00 0202 93 93 3 94 a 00000070PRFUPOP00 0 94 NR PP ais 95 Il TRALD ES RS 96 4 ET OO ERE CRE UE 97 Il TACO A 97 9
159. Hb Hb 10g d1 2 3 Un 4 0 0m 1 2 29 HLA ili HLA HLA HLA
160. eid Post Donation Information Yi
161. gt 3 X10 kg Il i 17440 21640 30850 66450 166 Cr Il 50 1 2
162. 2 3 I II 1 4
163. 20 1 56 SE
164. 2 1 1 5 ae l OR VVR VVR We 50 40 A 5 Atropin1 2A 5 10 ex Atropm1 2A 5 1 3 10 5 40 50 1 40
165. 25kg 1 2 3 4 5 HLA 6 ABO Il 1 PT GVHD CMV Rh 7 ABO IN 69 1 8 10 3 4 In In 13 500 L 10 1 V n
166. 3 1 2 10 15m1 3 1 70 90mmHg 0 3ml 2 70mmHg 10 1ml 1 gt 2 3 1ml 4 20 40
167. ee SW Dr 28 91919191 91919191 43 747 C cm kg Nvpa ml r Xn ls 11 2008 1 PC
168. 4 H I V 1 2 4 8 9 10 INDEx HBs HCV GQOT GPT 4 106 ss Lot No 0 NO OO
169. h I L In L 6 1 KO 10 12 1050 28 30 1050 10 IgG
170. 1 2 3 4 PT GVHD 5 6 7 8 ABO Rh 9 CMV 66 In 1 L 2 5 Il I 1 2 gz L 1 1
171. 7 0 2X101 x x2 3 mL X103 115 3 1 1 KK PT APTT 2 17 2 3 Upshaw Schulman 2 1 2 10 20mL kg 12 24 2 10mL kg 2 3 3 4 1 ABO Rh
172. ABO Rh D Rh D ee Rh eh 20 30 ABO ABO 14
173. 1 50 1 AABB we l 80mmHg 1 CG A PC 3 1 Il
174. 1 10 15 1 10 11 2 1 a 1 1 1 169 OK
175. 109 10cm 1 49 0 59 5
176. Il oO Rh Rn RhC Rh Rh Rh Rh RhC Rh Re 1 Rho Rho D Rho D 2 Donor 5 Donor 95 Donor Donor 4 il 126 AB0 1 1 RCC LR WRC LR 2
177. 1 10 159 HT gt HL 99 5 FE GD 2 3 HTLV 1 T
178. 1 2 CMV CMV 1 CMV 2 3 4 CMV HIV 1 CMV CMV RCC LR CMV 1 2 CMV 3 CMV
179. 1 2 Il 2 5 ln 1 3 1 Il 1 1 1 67 L 5 1
180. 64 OO 1 PF l 1 2 Hb 7g dL Hb 10g dL B12
181. 61 VI l RCC LR 65 I 67 70 VF SM 73 1 CN GOO RS ES OR a 76 2 77 1 77 RCC LR Hb 78 78
182. L 1 1 nmn 20G 40 60m1 22 24G 20 50m1 2 3 10 g d 1 1 L 200ml 1 Spectra TBV 15 ITBV 10 AutoPBSC 165 ml 1100 ml 1650 ml TPE 165 ml 1133 ml 1700 ml RBCX 170 ml 1133 ml 1700 ml WBC 284 ml 1893 ml 2840 ml 165 Im 10 15 1 3 ACD vaso vagal reflex VVR hypovolemia
183. 18 1 5g dL 8 9 OD DOD LE 7 2 3 g g dL dL X2 5 0 4dL kg
184. 3 2 6 20 24 207C 4 6 4 2 5 1 1 2 3 4
185. 44 3 444 457 1998 18 15 3 74
186. l LOTLNO 2 2 L 22
187. A A ld es 73 5 6 7 50 18
188. 400mL CPD 56mL LR 200mL CPD 28mL MAP Il 46mL 400mL CPD 56mL MAP 92mL 200mL CPD 28mL LR I 120mL 400mL CPD 56mL 240mL ACD A 7 16 1 FFP 5 Il 1 ACD A 8 13 1 LR 77 5 kg 10 kg 15 kg 20 kg 25 kg 30 kg 35 kg 40 kg 45 kg 1 7 6 8 8 2 5 1 9
189. 1 NAIT PTP 4 TTP HUS 5 Il In 68 6 HIT h 7 8
190. 150 4 1 2 3 a 10 15cmHg b 1 000ml 3
191. 7 15 1 2 V LL V
192. rgG Dia V VI A1 Bcell A B ABO 4 1 PEG MTS 113 4 FE 1 2
193. 2 3 2 4 2 3 50 22 1 1 9 1
194. 4 2
195. 400m 1 X 50kg 5 10m1 kg Hb Hb Hb x Ss TB V 138 3 1 3 4 CPD 21 CPDA 1 35 MAP 21 5 1 134 5 1 2 100 200mg 8 6mg kg
196. Rho feto maternal hemorrhage FMH D D Rh immune globulin RhTg 1 2 4 16 32 NST tgG type 2 4
197. 118 1 Il Rh IMNSs Lewis ni Duffy Kidd Diego Lutheran Kell Xg Jr Jsb El uk Buk lk te 119 2 HDN
198. 3 1 3 6 8 10 1 172 4 1 9 J 4 2 6 3 4 5 5
199. AT 1 2 Winor CD 1 lt 2 2 4 gt 1000mg FOY30mg kg day 5 500m1 2 4 2000U 1 500ml 1 89 AB O
200. Hb 8 10g qL 2 2 1 15Gy X RCC LR 2 1 GVHD 3 RCC LR 1 10 20ml kg 1 2 ml kg
201. Rh 43 gt 1 200m1 lt 400ml gt 20
202. 178 5 1 2 2 6 1
203. 3 4 H n 5 5 1 19 54 65 10 PBSC 157 G CSF G CSF
204. 2 3 72 4 IVH 5 6 3 CRP WBC NYHA
205. A B ABO VNTR 6 I 5 5 2190 2191 RCC LR
206. HDN Hemolytic Disease of the Newborm 10 12 28 30 1 119 D HDN D 16 32 E HDN D
207. 1 2 1 142 8 9 20 80cm Il I
208. E 6 5 18
209. HLA 2 1 200ml PRP ln 2 3 HPA 3 HPA 4
210. PTR platelet transfusion refractoriness HLA PTR HLA 1 1 2 HLA 2 3 3 4 HLA HLA ABC typing 10 000
211. 2 15 1 54
212. 16 4 0 I 2007 7 2 6 S ALT S GPT 100IU L 2 HBs HBV DNA B C HCV HCV RNA B C Il
213. I FEP 1 2 li ABO A B 1 1 2 3 8 DTT 2ME POD 2 mL 2 mL 127 CMV Vox Sang vol 83 2002 CMV 1 CMV
214. 1 1 1 l SOOO 4 24 3 1 n 176 2
215. ABO Major Minor 88 gt 0 1n n 4m1 ICU 3 RCC LR
216. Ca K 4 Alb 19 1 1 1 1000 2 1 MP 300 20 2 2 ME BP 102 21 et 2
217. CMV 2 128 EE EEEREYEHPPHEPPP 0207 130 SA RR 131 ee 08000000 132 A 134 135 ea ee 137 OD 139 140 143 A 0 RE 144 ED Dn a ER 145 ww 145 147 147 129 1 GVHD
218. 30 HLA HLA HLA HLA L ICFA 3 4 31 Rh D Rh 1 4 n 2 L L ABO Rh Minor Rh ABO Rh I 3
219. AIDS B i ai 108 B
220. 6 I 13 pppupwpp pp pppp pp p pp pp pp pp p pp pp ppp 2190 2191 PHS6081 0 RCC LR AB FFP 0 RCC LR AB FFP AB FFP O RCC LR
221. Ht Et 3 a b c 10 10 15mTkg 10 12
222. 3 5 1 5 6 7 2 2 3 8
223. 4 4 f 1 2 4 102 7 110 3 1 2 3
224. 70 90 mmHg 1 000m1 70mmHg 2 000ml 20 30 5 5 6mg kg 20 6 C WRC 95 transfusion related acute lung injury TRALI HLA
225. 17 37 17 2 15 59 4 135
226. Hb Hb 800ml 1 000ml 40 m 152 5 1 400 1 200ml
227. c 1 000ml 2 000ml d 40um 6 a b 6 4 a b
228. 1 6 4 C 24 2 114 3 30ml min 24 X HLA CMV HTLV I GVHD X Xx Xx 2 1 1 3 lL
229. FE AB0 2 ABO 2 RCC LR FFP XABO MHA 1 IE LE 4Z2 M6 2A RCC LR 422 1 A EE ADO ME DAE FFP PC 2 450 MM LI 1A FFP PC gt gt gt gt gt gt x4BO 2 FE
230. S ALT F F 109 16 4 1
231. RCC LR In ml h Il 1 3 5 18 In 3 3 6 6 el 117 R 1 I 2
232. 3 5 15 1 Oe 2 3 45 36S 3Cm 43 2k9 8 2 Ol Pr 3 BE FFP 1 MEMO
233. 1 2 3 4 5 vw 1 2 3 4 5 6 7 8 9 10 3 1 2 1 1 1 2 1 2 7
234. 4C 3000rpm 30min 4 FFP 5 5 10m1 20 135 A B A B 1 1 A 5 10ml 0 717 5 ml 67 2mg ml 336 mg 500 ml 3 9 mg ap 400m 1 3 ml 80 mg ml 240 mg 300 ml 5 88 mg 79 47 688 136
235. 8 I t 4 IT 5 n 6 tt j 7 10 T amp S MSBOS 1 1 UMS MRSA03Sva5DotSu 85 ca 13 1 14 1 BA 15 29 L 23 24 24 25 26
236. B 1A 10ml n 5000 37C Ca 3 ml 80 mg ml 240 mg 250 ml 5 90 mg 77 nf y 45 092 9 5X4 8cm 250 8 mg 62 9 EA 64 484 6 1 Hb TBV MSBOS SBOE TBV 1 0 168H3 0 050W 0 444 1 0 250H3 0 063W 0 662 H m W kg SBOE Surgical Blood Order Equation MSBOS SGBOE T amp S
237. 37 1 ABO IgG C3 b C3 d 1 AIHA 2 3 4 5 I I HLA HPA HLA HPA HLA MHC MHC HLA hu
238. Hb 9 0g dl Hb Hb 10 0g ql H b 8 0g dl 1 10 Hb 1 g H t 396 133 2 GOT GPT GOT GPT HBV HCV HIV HTLV I
239. PS 70 80 E 63
240. 1 1 L L 1 5 1 5 1 1 In Il 3 5 1n 5 1 1 L 1 3 Il 1 oozing
241. 7 3 19 8 20 C 5 10 20 Dc 108 1 10 11
242. CLEIA B19 CLEIA g 200mL MAP 2 91 0 03 0 19 0 30 7 vy 0 04 1 44 ACD A CPD CPDA 1 0 05 0 50 0 50 4 40 5 26 5 26 1 60 0 65 0 65 4 40 4 64 5 80 gt 2 7 vy L LR 200mL CPD 28mL 0 99 n ATP pH ATP
243. BCG PBSC PBSCH 1 80 000 AL PBSC PBSC 2 COBE Spectra BCT AutoPBSC 16Sml WBC 284ml 60 80mL 150 200mL kg 250mL kg
244. G CSF G CSF 6 PBSC 1 PBSC PBSC G CSF G CSF G CSF G CSF G CSF gt G CSF 50
245. nm 2 1 oN MA ll 3 4 Il nh 70
246. stem cell W 3 4 2 5 2 5 A 500m 1 162
247. 1 4 167 1 3 8 10 7 5m g d 1 HPT40 Coma Gra deL 2 5 7 PT HP 6 4 CH 20
248. 3 2005 1 1 1 1000
249. GVHD 101 gt GVHD O ITH HH GVHD 15 50Gy GVHD T 15Gy 50cy 1 15Gy FFP RCC LR 1 2 3
250. 4 6 6 4 OT 6 Miles 6 6 Y a 6 4 Crt 4 BMT 4 4 4 4 4 4 6 _ 4 THRO6 i 6 LAVBD 6 12 17 00 1 ABO Rh D RCC LR FFP PC 2 2190 2191 PHS6081 2ml
251. 80 90 2 000mL nn 0 2 E gt 2 Il
252. 112 ML RE L 4 4 0 5 1 ml 0 5 ml 2 1 A B A B MTS A B H D 2 MTS AHG4 BNZ2 O TT Dia V VI cell AHG6 A1 B cell
253. 91919191 91919191 43 eseee eee eer A lt gt JooC LT POOL Hb PT DD F WR ND 5 rl gm by 1 2 3
254. IUT 1L 1 D 400ml 1 3 7 P 700ml 1 5 4C 2 M 850ml 1 2 5 4C ABO Rd 400ml i OT 120 3 D D Rh Rh D D D D 1 D
255. 1 GVHD 1 2 1 GVHD 1 GVHD Im 2 Il n 3 4
256. 1 3 3ml 1 5ml 3 2ml 3ml ABO Rh 6 2ml ABO Rh D 1 2 My 3 4 HLA 5 6 2ml 1ml CBC EDTA 4ml 1 39 3 5ml 42 160
257. 123 TTP 1 Il 1 5 1 2 5 1 3 3 1 1 20 30mg day 2 1mg kg day gt globulin 400mg kg day 2 1 5 4L 2 5 L 20 30mg day 1 2 y globulin 400mg kg day 5 1
258. 15 RhD 0 5 RhE Fya amp b Jka amp b 0 5 1 3 ABO ABO 2
259. 3 preclotting 4C cryoprecipitate
260. In 200ml400ml 1 O A Rh Rh O Rh A Rh B Rh Rh O Rh B Rh O Rh O Rh O Rh AB Rh AB Rh Rh 0 A B AB Rh 1 Rh ABO Rh ABO Rh ABO A Rh A Rh Rh AB B 0 A Rh B Rh B Rh Rh AB A O B Rh O Rh 0 Rh Rh AB A B O Rh AB Rh AB Rh Rh A B O AB Rh ABO Rh AB
261. l 1 l 1 5 40 50 cm VS LL 1 In 1 141 8 4 1 1
262. 3ml 2 4 105 5 4 HBs HCV GOTGPT HIV 1 2 HTIV 1 2 4 HIV 1 2 HIV 4 6
263. HBs D Rho l VM l L X I VI I VM D Rho D 1 B 1 A I VM I 1 1 X 1 VI I VM 1 1 1
264. HTT HTT HIT Tr ID 2 Na CBC EDTA 3 850 2ml 3 4 1 2 CO 5 1
265. Il 5 10 L 4 24 2 5 DIC DIC 6 1 2 3 5 g ln DIC 1 2 gL 1 2 g
266. 2 4 3 3 6 PC PC 3 10 T6S MSBOS T amp S MSBOS T amp S Type and Screen T amp S Rh
267. ee 178 5 ee 179 1 PS 179 2 179 6 oo 179 1 Il PPP 179 2 ee 179 3 1 a ERE CEE EE EE a ERR RE 180 171 bj 10 4 24 24 7 20 1 2
268. 11 30mmHg 12 30mmHg 13 100 14 15 16 17 TRALI TACO 24 6 6 94 96 97 84 GVHD PTP 1 6 5 12 24 1 28 4 101 99 86 99 93 85 3 1 ABO 5 30
269. DIC K 2 1 X 15Gy L 24 ABO 0 RCC LR 1 AB FFP Rh D Rh D ABO Rh ABO Rh RCC LR ABO Rh FFP ABO Rh RCC LR FFP DIC ABO Rh RCC LR FFP ABO Rh 3 200ml kg 859 100ml 4
270. 0 FFP AB 20 AB Ca K DIC ABO l LL RCC LR 2 FFP or PC 2 2 Major 87 1 Major 1 2 3 4 5 4m 1 EDTA 1
271. I 5 6 Ei HLA GVHD 9 1n 3 GVHD GVHD nl
272. 3 4 PBSCT 3 159 gt MN 16 18G OO lo W 3 20 24cG 118G 18 22G GO CO PBSCT In PBSCT 2 3 lt gt
273. n 80 1 7 1 DIC 1 2 5 10 15 20 5 kg 350ml 3 8 7 6 19 0 10 kg 700ml 1 9 3 8 9 5 19 0 15kg 1050ml 1 3 2 5 6 3 12 7 19 0 20kg 1400ml 1 0 1 9 4 8 9 5 14 3 19 0 25kg 1750ml 0 8 1 5 3 8 7 6 11 4 15 2 30kg 2100ml 0 6 1 3 3 2 6 3 9 5 12 7 35kg 2450ml 2 7 5 4 8 2 10 9 40kg 2800ml 2 4 4 8 7 1 9 5 45kg 3150ml 2 1 4 2 6 3 8 5 50kg 3500ml 1 9 3 8 5 7 7 6 55 kg 3850ml 1 7 3 5 5 2 6 9 60kg 4200ml 1 6 3 2 4 8 6 3 70kg 4900ml 1 4 2 7 4 1 5 4 80kg 5600ml 1 2 2 4 3 6 4 8 1 In 30
274. 1 fy 4 1 1 2 D ABO Rh 3 4 1 1 5
275. 50 PBSC 1 8 4 5X10Vkg CD34 4 5X109 kg 2 5X105 kg 5 PBSC PBSC CD34 2X109kg
276. 2 CX EM 83 4
277. 75 000 nL G CSF 4 G CSF 7 1 ECG PBSC 2 PB SCT lt gt 16 18G WW 12Fr 20 246G O I18G 18 22Gc 164
278. poor mobilization poor mobilization PBSC PBSC 161 PBSCT 1 PB SCT 2 14 7 10 3 5 G CSF 4 WBC 3000 7 1 W CD34 CD34 CD34 PBSCH
279. 50 3 24 25 AABB Blood Transfusion Therapy 7th ed 2002 p27 79 D 200mL 400mL 2 n 20 n 10 n 10 Na mEq 174 5 175 4 153 4 137 145 Cl mEq L 81 9 75 2 76 3 99 107 mg mTL 362 20 352 19 366 35 70 110 mOsm kgHzO 290 12 314 1 297 3 276 292 pH 7 40 0 03 7 38 0 03 7 29 0 10 7 31 7 51 mg mL 10 1 10 1 3 4 0 8 2 4 4 3 gdL 6 3 0 6 6 0 0 2 5 6 0 2 6 8 8 2 g dL 4 0 0 3 4 0 0 1 4 0 0 3 4 0 5 0 mg dL 244 19 238 21 256 60 150 4003 1 Blood Information No 1 1987 2 SRL SRL 1996 3 Il
280. C 40m g d 1 DNA RPGN CNS 7 Rh 2 0 X64 2 0 Xx128 8 4 2 ABO 9 5 10 7 3 11 7 3 12 1 13 3 3 14 1 15 2 3 16 10 3 17 12 3 18
281. 1 ABO Il Landsteiner ABO 2 Rh L 4 A B O AB ALB H A B 1 A Rh D C c E e Rh 0 5 200 1 ABO II L A BB 1L FE fi hn 1 I MN a ABO Rh
282. 11 6 9 Es F 20 10 28 23 11 28 Nl 175 2
283. T amp S MSBOS 26
284. 4 10 409 1 2 3 4 74 1 2 3 4 5 75 ER X 1 200mL 1 7 933 2 6C O LR 400mL 2 15 867 21 XxX
285. Gsovolemic method 116 1 1 36 Il DIC R _80 90ml kg 5 CD 1 LU 2 se lt gt 2 13 00 a CO 1 gt oo 3 1 2 L 3 RCC LR FFP PC
286. NAP We FDP 15 00 FDP 13 00 AT PLG 2 HI 1 TAT PIC 21831 D D C S PIVKA XT EE PAI1 40 AIN 2 3 1 4 2 5 3 6 7 8 9 10 INDEx 4 2222 ABO Rh Rh 2 BO HIT HIT heparin induced thrombocytopenia 4
287. 1 Ei 2 3 Ei
288. 196 ABO 127 CMV 1 TN ed ey dd A 128 IX A A A SE ee EN 129 X PBSCH Il DR RR RS eS pt 155 PBSCT Co 156 PBSCT oe 162 XL 167 Il Ee 168 Il 4 SO ee ed ddr dhe NO A ar ROE NN RC 169 t 169 172 174 180 1
289. 2 15 SpO2 PDA 2 6 SpO2 PDA 3 5 15 7 2190 2191
290. 260 3 7 167 270 1 30 34 30 34 42 167 0 30 34 9 10 500 2 079 ID 1 Z008 11 06 DO 00 PT el
291. 6 10 146 13 6 200ml 250 750 6 1kg 4ml 250 750 6 200ml 500 1500 6 1kg 4ml 500 1500 4 500 600ml 600ml
292. 79 OO 80 1 80 t t 81 83 t t 84 j 86 99 100 GVHD 101 103 ii 105 i vu u 106 107 108 HDP CHC 110
293. DIC 6096 Il 6 93 3 Al lt T AN 1 1 1 2 5 7 1 l Il
294. ln Rh D E Il SA st ABO 1 L 66 1 LDH GOT 1 BUN
295. 150 3 0 VVR 7 25 27G VVR D Wap SL Il 1n 169 1 F VVR 5 Ds
296. 4 1L 12 5ml 1 1 1 5 1 1 1 1L 0 1 10 1 hn D I Il hn D 1 12 5ml D 1 D D D gt gt
297. 596 2596 17 17 PHS6081 40 50 14 10 17 ICU 3 MSBOS T amp S 12
298. 1 Sayama Net 2 48 1 49 2 50 52 2
299. 3 3L 2 a b 3 5 pg kg min c Frusemide250mg 4 DIV 1ml kg hr DD CVVHD a 500ml day b 24 4 6mEq L GIK 50 10 10 20ml IV catabolism
300. 9 06 4301 3100 9 5 4 5 FAX 072 295 8737 URL http www pref osaka jp kodomokatei jigyou index html gt 1 10 06 6722 7076 9 00 17 45 06 6945 1321 17 45 lt 9 00 52 3 x
301. ED lt 1 2 24 1 1L 1 5 10 90 ABO
302. 2003 11 17 2003 11 17 2007 06 22 _ Dr 2008 10 30 200F ET 8 200 E G ID AN 6 D r
303. HLA HLA E 3 4 2 2 7 RCC LR 0 9 68 7929 0 4 0 3 0 01 0 05 0 01 0 15 0 7 29 3964 0 1 0 35 0 03 0 03 0 23 3 7 128 3491 0 29 3 0 0 03 0 11 0 26 1 5 225 15384 0 27 0 91 0 02 0 06 0 007 0 2 0 01 1 8401 0 01 83 2 1 38C 1 2 3 4 5 6 7 8 9 10
304. c 151 a b c 5 Hb 1 000ml 1
305. 4 1 2 3 4 5 2 0721 25 1131 072 276 7123 t
306. 91 L Rh Duffy Kidd Diego Lewis MNS 2 D C E c e Fy Fy Jk Jk Di Le Ley M S N S s Pi 8 Ag 92 0 5 12 50 44 9 1 80 27 29 90 78 32 22 28 89 0 3 65 gt iRRR RR RR RY 1 1 2 1 O 2 50 47C 42 3
307. Rh ABO Rh A Rh A Rh AB Rh A Rh Rh Rh AB Rh B Rh O Rh AB Rh O Rh O Rh AB Rh AB Rh 32 Rh Rh Il 1 1 D D 6 i 1 D 4 7 Rh D 1 10 ln D 2 3
308. 2 4 PargG 2 NATTP ee 1 TTP 2 1 3 4 IgG HLA HPA 3 NAITP 1 2 HPA 3 4 4 NATTP 1986 2011 3 HPA la 1 HPA 5a 2 HPA 2b 2 MDA Sb 18 HPA 3a 22 4 HPA 4b 5
309. D L D 1 Rh 1 ll 1 DD li 1 1 1 1L L ln 1 j h IgG
310. II I II I 40 i i II II 1 59 p56 60 2 1 2 3 200 300ml 1710 1 5A 1 2mg 40mg ml 172 1A 0 25 0 5mg
311. nh 0 5 1 15 30 nm nl 1 lt
312. 4 83 8 89 3 8 2 1 7 0 3 36 3 4 8 49 5 4 8 56 6 4 6 0 2 0 1 4 6 0 7 6 2 0 8 7 1 0 8 78 i K DDAVP FmP 4 75 100mg dl 3 6 50 40 2 5 40 80 V 15 25 15 836 80 2 VI 5 10 2 7 70 80 VI 10 40 8 12 60 80 3 10 40 18 24 40 50 X 1 10 20 1 5 2 50 15 30 3 4 90 100 XX 1 5 6 10 5 100 25 50 3 5 1 214
313. 6 ABO nh 72 1 30 NN 3 0g dL i ed 1 000mL 2
314. CSF PBSC PBSC PBSCH 2 G CSF ECG X CBC 0 OR G csF 4 wm 1 1 10W g kg PBSCH 1 1 CBC x 1 1 1 1 ECG CD34 1 6 00 2 5 2 5 A 500m 1 156 SR 0
315. Il REESE 97 98 4 1 1 eR EE EE CE EE EE EEE 99 Il PTP Se 1 99 5 Il A SR RR ETE EE EE EA 100 100 6 GVHD DOWNT 101 7 SS REE SE EE 103 82 1 2191 he TRALI X PDA 5 1 5
316. RR wR 107 HBV
317. 000 AL G CSF 75 000 nL G CSF PBSC 10 g kg G CSF 4 6 G CSF 4 6 1 2 G CSF 4 2 PBSCT G CSF a ho AST ALT LDH ALP 0 71 33 28 149 11 11 G CSF 2 3 G CSF
318. 0mg dL V XI PT INR 2 0 30 1
319. 1 2 ASA physical status I HI 1 149 1 NYHA I I 2 149 li 70mlX kg 1 3 ln kg 5 10ml 50
320. 1 _ 120mL 1 8706 70 0 LR 240mL 92 17 414 20 1 450mL 5 22 961 HLA 1 1 20mL 7 618 2 40mL 15 236 1 1 5 100mL 38 792 20 24C I 10 200mL 77 270 72 15 250mL 115 893 20 250mL 154 5238 76 HIV HIV 1 2 CLEIA 20 NAT HTLV 1 HTLV 1 CLEIA HBV HBs CLEIA HBs CLEIA HEc CLEIA NAT 20 HCV HCV CLEIA NAT 20 MR ALT
321. 1 5 1 3 1 1 0 9 0 8 LR n 8 pH ATP mol gHb 2 3 DPG mol gHb Hbag dD mEq mEqL mnEo RCC LR Hb g dL LR n 8 pH ATP mol gHb 2 3 DPG molgHb Hb Qg7dL mEq mEq L mo 2 1 2 50 kg 0 8 1 5 7 6 55 kg 0 7 1 4 5 0 60 kg 0 6 1 3 3 8 65 kg 0 6 1 2 3 0 70 kg 0 5 1 1 2 5 75 kg 0 5 1 0 2 2 80 kg 0 5 0 9 1 9 90 kg 0 4 0 8 1 7 100 kg 0 4 0 8 1 7 14 21 7 23 0 03 7 08 0 02 6 87 0 02 6 71 0 03 5 5 0 9 7 3 0 9 6 5 0 9 6 0 1 1 14 5 09 12 2 18 3 5 1 5 0 3 0 4 12 8 3 5 25 6 5 4 28 9 6 3 42 7 9 2 124 9 1 7 114 3 1 5 109 8 1 0 106 5 2 4 1 2 0 1 19 3 2 1 830 5 2 9 38 7 2 6 0 2 0 1 2 5 0 3 9 0 4 4 9 0 4 1 7 14 21 7 20 0 02 7 06 0 02 6 84 0 02 6 70 0 02 6 3 0 7 6 4 0 8 6 4 0 6 5 9 0 6 14 0 1 4 9 7 2 6 2 8 2 0 0 6 0 9 12 8 4 3 24 8 7 1 85 0 8 2 49 3 15 6 123 4 1 6 100 1 3 3 92
322. 200 Hb 40 1 Hb 40 gdl us 2 T amp S 137 Hb 10g d TBVX 1 10 Hb 160cm 50 kg Hb 12 gd 2 MSBOS SBOE 4 800ml TBV 0 250 X1 63 0 063X50 0 662 3 512 1 3512ml Hb 10g dl 3512X 1 10 12 597ml Hb we Hb Hb 10g gl 1
323. 3 ABO Rh ABO Rh Lo t Ei
324. 3 0 D 1 2 Il Hb Hb g dL g dL 400mL 50kg 35dL Hb 19g dL Il 70mL kg dL kg X70mL kg 100 L 2 LR 280mL 1 Hb 19g dL X280 100dL 53g Hb 1 5g dL
325. 58 5 6 3 nn 1 Il 1 hn
326. 700 ml RBCX 170 ml 1133 ml 1700 ml WBC 284 ml 1893 ml 2840 ml 160 3 30 ACD vaso vagal reflex VVR hypovo1emia 5 10 ml hr
327. 9191 AR 91919191 sy a a 3 LABO B Rh 2006 11 01 2007708 22 2190 2191 pA MAP FFP 11 00 1 2003 11 17
328. D n gt D I D FFP 1 D Rh 2 3 5 19 651 4 D 33 FE
329. b 1 HPA 3b 1 1 Abra 7 HPA 3a 5b 1 MPA tee 1 HPA 4a 8 1 Nal toni AU HPA 4b 66 1 122 2 NAIT 1 HPA 3a Baka HPA 4a Yuk 100 HPA 4b Yuk HPA 5a By HPA 5b Brg HPA 6b Ca Tu9 Naks
330. man leukocyte antigen PTGVHD HLA 38 ABO Rh D Rh 17 00 9 00 2ml 1ml 2ml 1ml 4m 2 3m 2 4ml 2ml 3ml 2ml 4ml 2ml 4ml 2ml 3ml 1 5ml 4ml 2ml ABO Rh D 2ml 1ml HLA A B C DR 4 HLA 4 A 6 4ml 2ml 4ml 2ml
331. ml kg h WB 1 In 97 _ L 3 98 L 1 O 4 EE ABO
Download Pdf Manuals
Related Search